Champions Biotechnology Reports Fiscal 2009 Full-Year Financi...(g statements. One should not place undue...)

Date:8/27/2009

g statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Biotechnology's Form 10-K for the fiscal year ended April 30, 2009 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Biotechnology's future results, levels of activity, performance or achievements may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Biotechnology's expectations, except as required by law.

www.championsbiotechnology.com

www.personalizedcancertreatment.com/

'/>"/>

SOURCE Champions Biotechnology, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
2. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
3. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
4. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
7. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
8. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
9. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
10. Malaysian Biotechnology Sector
11. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan